Telemedicine marketing in the UK now sits at the intersection of digital healthcare demand, regulated clinical delivery, prescription medicine rules, platform certification, patient trust and sensitive health data. The commercial opportunity is substantial because consumers are increasingly comfortable managing healthcare digitally, but the acquisition journey has to reflect what the service actually does and which regulator, professional standard or advertising policy applies.
WLW FUTURE reviewed current 2026 guidance from the Care Quality Commission, General Medical Council, NHS England, Information Commissioner’s Office and the advertising policies published by Google, Meta and TikTok. The aim is to show healthcare leaders where digital demand is increasing, where marketing exposure sits and where a stronger customer journey can create defensible growth.
Research boundary
This is a B2B digital marketing and commercial intelligence report. Regulatory and platform sources are linked throughout. Providers should obtain appropriate legal, clinical, professional and regulatory advice for specific services, prescribing models and campaigns.
This is a B2B digital marketing and commercial intelligence report. Regulatory and platform sources are linked throughout. Providers should obtain appropriate legal, clinical, professional and regulatory advice for specific services, prescribing models and campaigns.
41.9mNHS App account registrations by the end of June 2026
77.3mNHS App login sessions recorded during June 2026
15.1mdistinct users logged into the NHS App during June 2026
7.39mrepeat prescriptions ordered through the NHS App during June 2026
The headline findings for telemedicine marketing in 2026
The market signal is clear. Digital healthcare behaviour is established at scale while regulation and platform controls are becoming more specific. Providers therefore need marketing architecture which reflects the difference between a general online consultation, a prescription service, an online pharmacy, diagnostics, weight management and other treatment pathways.
Digital healthcare behaviour is mainstream
NHS App usage reached more than 77 million login sessions in June 2026. This does not measure the private telemedicine market, but it does show that large numbers of UK patients are already comfortable accessing health services through digital interfaces.
Online care is still regulated care
CQC says the standards applied to online primary care are comparable with face to face services. Video consultations, remote advice and prescribing through online forms can all fall within regulated activities.
Remote prescribing needs clinical safeguards
GMC guidance says professional standards apply equally to remote consultations and face to face care. Identity, consent, continuity and the adequacy of information available for safe prescribing remain central.
Platform eligibility is service specific
Google, Meta and TikTok do not treat every telemedicine model in the same way. Prescription services, general telehealth, online pharmacies and medical institutions can face different permissions and certification routes.
Trust signals are part of conversion
Patients need to understand who provides the care, which organisation is regulated, how clinicians are registered, what the consultation costs and what happens if remote care is not appropriate.
Health data changes the marketing rules
ICO guidance treats health information as special category data. Using health information or inferred conditions to target direct marketing generally requires explicit consent as well as an appropriate lawful basis.
Digital healthcare demand is already visible at national scale
NHS England Digital reported 41,888,477 all time NHS App account registrations by the end of June 2026. During June alone there were 77,258,823 login sessions and 15,144,846 distinct users. Repeat prescription orders reached 7,387,605 for the month. NHS App statistics, June 2026
Those figures should not be presented as private telemedicine market size. They are useful because they demonstrate the behavioural baseline providers are competing against. Patients increasingly encounter healthcare interfaces which support login, prescriptions, records, messaging and remote access. A private service which feels less clear or less trustworthy than the digital healthcare experiences people already use can lose confidence before the consultation begins.
The direction of travel is towards more remote access, not less
NHS England is also developing NHS Online for planned specialist care from 2027. The model includes online consultations, digital prescriptions, advice and test or treatment booking through the NHS App when remote care is appropriate.
2027NHS Online is planned to begin offering specialist online care through the NHS App.NHS England
Online consultationThe planned service includes direct digital consultation with specialist clinicians where the model is appropriate.NHS England
Digital prescriptionThe same planned journey includes digital prescriptions for use at local pharmacies.NHS England
The 2026 regulatory position starts with what the service actually does
CQC updated its online primary care definition in March 2026. It regulates providers in England where a regulated activity is delivered online, including care transmitted through text, sound, images and other digital forms. Examples include video consultations and prescribing medicines in response to online forms. CQC online primary care
From 22 June 2026 CQC also introduced additional supporting document requirements for new online primary care registration applications, including inclusion and exclusion criteria, a medical emergency policy and medical indemnity cover for online services. CQC registration guidance
| Digital service model | Marketing starting point | Operational or regulatory question | Marketing pressure |
|---|---|---|---|
| General online consultation | Can generally be promoted as a healthcare service subject to claims, provider regulation and platform rules | Is the provider within CQC scope and are clinician details, suitability and escalation routes clear? | Manageable |
| Remote prescribing service | Service marketing can be possible but public promotion of prescription only medicines remains restricted | Does the customer journey promote the consultation rather than a named prescription medicine? | High scrutiny |
| Online pharmacy | Requires pharmacy regulation and can trigger separate platform certification requirements | Is the service registered appropriately and is prescription medicine promotion excluded? | High scrutiny |
| Online diagnostics or testing | Can be marketed where claims, device status and follow up are appropriate | Who reviews results, what happens after the test and are diagnostic claims properly supported? | Review required |
| Weight management telemedicine | Demand can be marketed around the service while prescription medicine references create significant exposure | Is the campaign genuinely service led and separated from public POM promotion? | High scrutiny |
| Sexual health telemedicine | Remote care is established but specific professional and privacy considerations apply | Does the service reflect the appropriate identity, consent, confidentiality and clinical standards? | Review required |
Interactive telemedicine marketing risk checker
Screen the service, channel, claim and data use together
Choose the closest options below. The result is a marketing screening tool based on the public sources reviewed for this report. It does not replace legal, regulatory or clinical advice.
1. What are you promoting?
2. Which channel is central?
3. What does the campaign emphasise?
4. How is health information used in marketing?
Lower risk starting point
Keep the service, registration and channel aligned
A general consultation campaign with no health profiling and service led messaging has a more manageable starting position. Review provider scope, claims, platform rules and the destination before launch.
Remote prescribing and medicines need a separate marketing architecture
GMC guidance states that professional standards apply to remote and face to face consultations alike. If a clinician cannot meet safe prescribing standards remotely the consultation should move to a face to face model. Identity, consent, continuity of care and the adequacy of patient information all matter. GMC remote consultations
The GMC and other UK regulators also set out 10 high level principles for remote consultations and prescribing, including patient safety, identity verification, vulnerable patient safeguards and clear professional registration details. GMC remote prescribing principles
Marketing teams need the same separation. A provider may be able to advertise the existence of a consultation service while still being unable to promote a prescription only medicine to the public. The service page, paid advert, price promotion and deeper treatment information should therefore be designed as one governed journey rather than disconnected assets.
1. NeedThe user arrives around a symptom, condition, service need or desire for faster access rather than a promoted prescription medicine.
2. ServiceThe provider explains eligibility, practitioner role, consultation format, price and what remote care can and cannot do.
3. AssessmentIdentity, medical history, relevant records, consent and clinical suitability are gathered before treatment decisions.
4. OptionsBalanced clinical information explains possible next steps and when face to face assessment, testing or referral is needed.
5. Follow upThe patient receives appropriate treatment information, continuity, escalation routes and support after the consultation.
Google, Meta and TikTok apply different telemedicine rules
Platform eligibility should be checked independently from UK clinical and advertising compliance. The current position differs materially by channel.
| Channel | Current UK position | Practical implication |
|---|---|---|
| Google allows UK telemedicine providers to promote prescription drug services with limitations if they hold LegitScript Healthcare Merchant Certification and Google certification. Prescription drugs cannot be promoted in the ads or landing pages. | Certification needs to be solved before campaign planning and the landing page must remain service led. | |
| Meta | Meta says general telehealth services can be advertised without written prescription drug authorisation. Direct prescription drug advertising is limited to eligible countries which currently do not include the UK. | General telehealth acquisition and prescription medicine promotion need separate strategies. |
| TikTok | TikTok’s June 2026 policy does not allow prescription medicine advertising. It says online or app based GP services offering teleconsultation may be allowed in applicable markets subject to local approval and adult targeting requirements. | Check market eligibility before creative production and do not assume permission for the service extends to medicines. |
| Organic search | Organic content gives providers greater room to explain suitability, clinical process, practitioner credentials and service boundaries in depth. | Search content should answer the patient questions paid media cannot always address effectively. |
| Email and CRM | Direct marketing rules apply and use of health information or inferred conditions can engage special category data requirements. | Audience building and segmentation require a data protection review, particularly where health status influences targeting. |
Trust, registration and patient confidence are conversion factors
CQC’s April 2026 patient guidance tells people using online healthcare services to check where the company is based, which regulators it is registered with, who is dealing with the consultation, what the service costs, how information is protected and what follow up is available. CQC patient guidance
Those checks are also a useful conversion framework. A provider which hides regulation, practitioner details, pricing, identity checks or escalation routes forces the user to resolve uncertainty elsewhere. A stronger website makes this evidence visible at the point where doubt appears.
Make regulation visible
Explain CQC scope, relevant pharmacy regulation and service registration clearly where applicable.
Show who provides care
Practitioner names, roles, professional registration and relevant experience should be easy to understand.
Explain the price
State consultation fees, prescription or test charges and what may create additional cost before the user commits.
Explain the consultation
Tell patients what information they need, how long the process takes and what happens when remote care is unsuitable.
Use reviews with context
Patient evidence is stronger when it relates to access, clinician communication, follow up and the actual service journey.
Show escalation routes
Make face to face referral, testing, emergency advice and continuity routes part of the service explanation.
Health data can turn ordinary acquisition into special category marketing
ICO direct marketing guidance identifies health information as special category data. It says organisations should generally have explicit consent when using special category data for direct marketing and notes that profiling people to improve targeting may itself involve special category information. ICO direct marketing guidance
This matters commercially because telemedicine funnels naturally collect symptom, condition, medication, test and treatment information. Data gathered for clinical care should not quietly become an advertising audience. CRM segmentation, abandoned consultation journeys, paid media audiences and lifecycle automation need governance which understands the difference between operational care data and marketing permission.
Marketing data check
If a campaign audience is being built because somebody has a condition, is seeking a particular treatment or has disclosed health information, treat the data use as a separate compliance decision before activation.
If a campaign audience is being built because somebody has a condition, is seeking a particular treatment or has disclosed health information, treat the data use as a separate compliance decision before activation.
The telemedicine customer journey should reduce uncertainty before requesting sensitive data
Strong digital healthcare journeys answer practical questions early: who the service is for, what it costs, who the clinicians are, what happens in the consultation, what cannot be handled remotely and what happens after treatment. This creates a better conversion experience while supporting safer care.
Lead with the service need
Build landing pages around the problem the patient is trying to solve and the consultation route available to them.
Set eligibility early
Clear inclusion and exclusion information can reduce unsuitable enquiries and improve the quality of booked consultations.
Make the interface feel clinical
Forms and onboarding should feel secure, deliberate and proportionate when users are being asked for sensitive information.
Explain what happens next
Confirmation, response times, practitioner contact, prescriptions, testing and follow up should be visible before payment or submission.
Measure quality as well as volume
Track suitable consultations, completed assessments, treatment conversion and drop out rather than relying on lead volume alone.
Build acquisition by service model
A private GP consultation, diagnostic test and prescription pathway should not share one generic media and landing page strategy.
Benchmark your current telemedicine marketing setup
Use this scorecard as a quick internal benchmark. A high score does not certify compliance. It shows whether the principal commercial, regulatory and digital controls are connected before acquisition is scaled.
Current benchmark score
0/10
Start with the service architecture
The current setup appears to rely on disconnected checks. Connect provider scope, remote care standards, channel eligibility, data use and conversion measurement before scaling acquisition.
Where compliant telemedicine growth remains
The commercial opportunity is strongest where providers use digital access to remove friction without removing clinical confidence. Search depth, service segmentation, clearer trust signals, better onboarding and disciplined measurement can all improve acquisition without relying on aggressive medicine led promotion.
Own high intent search
Build authoritative pages around consultation needs, conditions, access questions, prices, clinician expertise and suitability.
Segment by pathway
Create distinct acquisition journeys for general consultations, diagnostics, prescribing, follow up and specialist services.
Turn regulation into trust
Use registration, clinical governance and professional standards as evidence which helps patients choose confidently.
Improve onboarding conversion
Reduce unnecessary fields, explain why sensitive information is needed and show the value of completing each step.
Measure commercial quality
Connect campaign data to consultation suitability, conversion, repeat use and service profitability.
Build AI citation readiness
Use clear service definitions, clinician reviewed information, evidence and structured content so AI systems can understand the provider accurately.
WLW FUTURE telemedicine digital opportunity review
See where your telemedicine journey is exposed and where it can grow
WLW FUTURE can review your website, search visibility, AI visibility, service architecture, advertising, channel eligibility, health data use, competitor position and conversion journey together. The output is a prioritised view of commercial opportunity, customer friction and marketing risk.
Request a telemedicine digital opportunity reviewFrequently asked questions
Can telemedicine services advertise in the UK?
Yes, but the answer depends on the service being promoted. A general consultation service, remote prescribing service and online pharmacy can face different regulatory and platform requirements. Marketing should begin by classifying the service model and the treatment journey.
Can a UK telemedicine provider advertise prescription services on Google?
Google currently allows UK telemedicine providers to promote prescription drug services with limitations where they hold LegitScript Healthcare Merchant Certification and Google certification. Prescription drugs themselves cannot be promoted in the ads or landing pages.
Can UK telemedicine providers advertise prescription drugs on Meta?
Meta says general telehealth services can be advertised without written prescription drug authorisation. Direct prescription drug advertising is limited to eligible countries which currently do not include the UK.
Can telemedicine services advertise on TikTok?
TikTok’s current healthcare policy allows some online or app based GP and teleconsultation services subject to market specific approval and adult targeting requirements. Prescription medicine advertising is not allowed.
Does CQC regulate online consultations?
CQC regulates online primary care providers in England where they deliver a regulated activity online. Its current examples include video consultations and prescribing medicines in response to online forms.
What should a telemedicine website show to build trust?
Users should be able to understand who provides the service, which regulators apply, who the clinicians are, what the consultation costs, how their information is protected, what happens during the consultation and what follow up is available.
Can telemedicine providers use health data for remarketing?
Health information is special category data. ICO guidance says organisations should generally have explicit consent when using special category data for direct marketing. Profiling people to target marketing based on health information can therefore create additional data protection requirements.
What should telemedicine providers prioritise for digital growth?
The strongest priorities are usually service specific search visibility, clear regulation and practitioner trust signals, better onboarding, disciplined channel eligibility checks, useful patient information and measurement which tracks suitable consultation conversion rather than raw lead volume.
Sources and methodology
- NHS England Digital: NHS App Management Information, June 2026. Used for registrations, monthly logins, distinct users and repeat prescription figures.
- NHS England: NHS Online. Used for the planned 2027 specialist online care model.
- Care Quality Commission: Online primary care services. Updated March 2026. Used for the current definition and examples of online regulated activities.
- Care Quality Commission: Online primary care registration supporting documents. Used for the June 2026 registration changes.
- Care Quality Commission: Choosing an online healthcare service. Updated April 2026. Used for patient trust and service information requirements.
- General Medical Council: Remote consultations. Used for remote consultation and safe prescribing principles.
- General Medical Council: Remote prescribing high level principles. Used for identity, safety, professional details and remote prescribing safeguards.
- Google Ads: Prescription drug services. Used for UK telemedicine certification and advertising limitations.
- Meta: Drugs and Pharmaceuticals advertising policy. Used for general telehealth and current prescription drug eligibility.
- TikTok: Healthcare and Pharmaceuticals policy. Last updated June 2026. Used for prescription medicine and teleconsultation policy.
- Information Commissioner’s Office: Plan direct marketing. Used for special category health data and explicit consent guidance.
Research note: NHS App usage is used as evidence of large scale digital healthcare behaviour in England. It is not presented as a measure of the private telemedicine market.
Commercial methodology: The risk checker and 10 point benchmark are WLW FUTURE planning tools derived from the current public rules and digital customer journey requirements reviewed above. They do not certify regulatory compliance.
